While the underlying mechanisms by which nociceptors could limit tumor angiogenesis in melanoma remain unclear, it has been speculated that neuropeptides such as substance P, VIP, tachykinins or CGRP could play a role. The gene discussed is TAC1; the disease is neoplasm.